[EN] DIARYLHYDANTOIN COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS DIARYLHYDANTOINE ET LEURS PROCÉDÉS D'UTILISATION
申请人:NUVATION BIO INC
公开号:WO2020113088A1
公开(公告)日:2020-06-04
The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation. The present disclosure provides compounds having hormone receptor antagonist activity. These compounds can be useful in treating cancer, in particular those cancers which can be potentiated by AR and/or GR antagonism.